Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 215 of the 219 references it cites were found in a registry or an index; 87 of the 126 sources its claims cite were checked for support.

HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells

Open access

Abstract

In solid tumours, cancer cells exist within hypoxic microenvironments, and their metabolic adaptation to this hypoxia is driven by HIF-1 transcription factor, which is overexpressed in a broad range of human cancers. HIF inhibitors are under pre-clinical investigation and clinical trials, but there is evidence that hypoxic cancer cells can adapt metabolically to HIF-1 inhibition, which would provide a potential route for drug resistance. Here, we review accumulating evidence of such adaptions in carbohydrate and creatine metabolism and other HIF-1-independent mechanisms that might allow cancers to survive hypoxia despite anti-HIF-1 therapy...

Overview

CoChat Summary

TL;DR

This review argues that hypoxic cancer cells can maintain metabolism and survive even when HIF-1 is inhibited, using compensatory mechanisms in glucose, glutamine, lipid, and creatine metabolism plus epigenetic and signaling pathways. The authors conclude that targeting HIF-1 alone is unlikely to be enough and that combination strategies will probably be needed.

Key findings

  • In HIF-1/2-deficient Hepa-1 c4 tumors, glycolysis still adapted to hypoxia: glucose uptake was unchanged by FDG-PET, ATP was about 20% of Hepa WT levels, and c4 tumors had a 4.5-fold higher AMP/ATP ratio with higher PFK-1 activity.
  • In HIF-1α knockout HCT116 colorectal cancer cells, glucose uptake was maintained by GLUT14 regulated by HIF-2α, and creatine metabolism became important for survival; inhibition of creatine kinase B (CKB) reduced clonogenic potential and 3D spheroid growth under hypoxia.
  • In Myc-overexpressing small cell lung cancer cells lacking HIF-1α, glutamine was critical and sufficient for ATP production: blocking glutaminase caused cell death, while glucose withdrawal did not affect viability.
  • The review highlights multiple HIF-independent adaptation routes, including epigenetic reprogramming, post-translational SUMOylation, spatial clustering of glycolytic enzymes (“G bodies”), PI3K-Akt-mTOR, 2-hydroxyglutarate, and AMPK/PGC-1α signaling.

Methods

  • Narrative review of prior studies on hypoxic cancer-cell metabolism, with emphasis on HIF-1-independent adaptation and resistance to anti-HIF therapy.
  • Synthesizes evidence from multi-omics studies (transcriptomic, proteomic, metabolomic), genetic knockouts/knockdowns, pharmacologic inhibition, and hypoxic cell/tumor models.
  • Main analysis is qualitative: comparison and integration of reported findings across cancer models, rather than a new experimental dataset or meta-analysis.

Limitations

  • The paper does not report a systematic review protocol, formal search strategy, or quantitative synthesis; this is evident from the text.
  • The authors explicitly note uncertainty in several areas, such as the exact mechanisms linking AMPK, 2-HG, PGC-1α, and hypoxia, and say that many findings “remain unknown” or “need further clarification.”
  • The evidence base is heterogeneous and often model-specific; this is evident from the text, which repeatedly contrasts Hepa c4, HCT116, SCLC, and other systems, some with intact HIF-2 signaling and some without.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/cells10092371

Cites

215 of 215 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 HIF-1 in normoxia and hypoxia. (A) In normoxia, HIF-1α is hydroxylated by prolyl and asparaginyl hydroxylases in the cytoplasm in an oxygen-dependent manner. It then forms a complex with VHL and other proteins, allowing it to be ubiquitnylated and degraded by proteosomes. (B) In hypoxia, the lack of oxygen-dependent hydroxylation and proteasomal degradation of HIF-1α causes it to accumulate. It then translocates to the nucleus and complexes with HIF-1β to form a transcription factor complex that binds to hypoxia response elements (HRE) within the promoter regions of target genes involved in cell proliferation, metastasis, glycolysis, angiogenesis, growth, and survival.
Figure 1 HIF-1 in normoxia and hypoxia. (A) In normoxia, HIF-1α is hydroxylated by prolyl and asparaginyl hydroxylases in the cytoplasm in an oxygen-dependent manner. It then forms a complex with VHL and other proteins, allowing it to be ubiquitnylated and degraded by proteosomes. (B) In hypoxia, the lack of oxygen-dependent hydroxylation and proteasomal degradation of HIF-1α causes it to accumulate. It then translocates to the nucleus and complexes with HIF-1β to form a transcription factor complex that binds to hypoxia response elements (HRE) within the promoter regions of target genes involved in cell proliferation, metastasis, glycolysis, angiogenesis, growth, and survival.CC BY · PubMed Central
Figure 2 Effects of the HIF-1 activation on the tricarboxylic acid cycle and associated pathways, including glutamine and citrate metabolism, in hypoxia. The mechanisms are highlighted in red, and the red arrows indicate the direction of flux via the metabolic pathways under the prevailing oxygen tension. (A) In normoxia, pyruvate produced via glycolysis enters the mitochondria, where it is converted to acetyl-CoA and enters the tri-carboxylic acid cycle (TCA). Citrate from the TCA can be exported from the mitochondria into the cytosol, where it is converted to acetyl-CoA for fatty acid synthesis. Cytosolic glutamine is converted to α-ketoglutarate and transported into the mitochondria where it enters the TCA. A key regulator of autophagy, Beclin 1 is inhibited by Bcl-2 and Bcl-XL, thereby decreasing autophagy. (B) In hypoxia, HIF-1 activation results in increased flux through the glycolytic pathway, as well as accumulation of pyruvate and conversion into lactate. BNIP3 and BNIP3L (not shown in this figure) are expressed under the control of HIF-1, which then interact with Bcl-2 and Bcl-XL to liberate Beclin 1. Beclin 1 induces mitochondrial autophagy, reducing the formation of mitochondrial reactive oxygen species under hypoxia. Fatty acid synthesis is maintained by reductive carboxylation of glutamine, formation of citrate, and conversion of citrate into acetyl-CoA in the cytoplasm.
Figure 2 Effects of the HIF-1 activation on the tricarboxylic acid cycle and associated pathways, including glutamine and citrate metabolism, in hypoxia. The mechanisms are highlighted in red, and the red arrows indicate the direction of flux via the metabolic pathways under the prevailing oxygen tension. (A) In normoxia, pyruvate produced via glycolysis enters the mitochondria, where it is converted to acetyl-CoA and enters the tri-carboxylic acid cycle (TCA). Citrate from the TCA can be exported from the mitochondria into the cytosol, where it is converted to acetyl-CoA for fatty acid synthesis. Cytosolic glutamine is converted to α-ketoglutarate and transported into the mitochondria where it enters the TCA. A key regulator of autophagy, Beclin 1 is inhibited by Bcl-2 and Bcl-XL, thereby decreasing autophagy. (B) In hypoxia, HIF-1 activation results in increased flux through the glycolytic pathway, as well as accumulation of pyruvate and conversion into lactate. BNIP3 and BNIP3L (not shown in this figure) are expressed under the control of HIF-1, which then interact with Bcl-2 and Bcl-XL to liberate Beclin 1. Beclin 1 induces mitochondrial autophagy, reducing the formation of mitochondrial reactive oxygen species under hypoxia. Fatty acid synthesis is maintained by reductive carboxylation of glutamine, formation of citrate, and conversion of citrate into acetyl-CoA in the cytoplasm.CC BY · PubMed Central

Verification

Claims the paper makes

57 Valid · 5 Not valid · 16 Not checked · 16 Own results and interpretations

40 more claims · 19 with their cited sources checked

Create a free account to see all 94 claims and to verify the 5 references still open.

See all claims — free account
  • Probably not a substantial claim. 9
  • It may state two separate claims as one. 44

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 219 references

Cited by

See all 169

Metadata

Authors
Lee, S.-H., Golinska, M., & Griffiths, J. R.
Affiliations
  • Hospital Sultanah Bahiyah (MY)
  • University of Cambridge (GB)
Corresponding author
Lee, Shen-Han
Venue
Cells
Publisher
MDPI AG
Published
2021-09-09
Volume
10
Issue
9
Pages
2371
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3197266090
Cited by
169
References
219
Citations by year
2026: 31 · 2025: 48 · 2024: 50 · 2023: 22 · 2022: 18
FWCI
2.71
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo
  • Apollo (cc-by)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
HIF-1, hypoxia, cancer metabolism, metabolic adaptation, HIF-1 inhibitors, drug resistance, ARNT, HIF-2, creatine metabolism, glucose metabolism, glutamine metabolism, lipid metabolism, epigenetic regulation, post-translational modification, c-Myc, PI3K/Akt, 2-hydroxyglutarate, AMPK, tumor hypoxia
MeSH terms
Adaptation, Physiological, Animals, Humans, Neoplasms, Signal Transduction, Cell Hypoxia, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells. https://app.cochat.ai/papers/10.3390/cells10092371
The paper
Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021). HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells. Cells. https://doi.org/10.3390/cells10092371

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.